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BSTRACT
 
Background
 
Normally, one pair of each of the
two 
 
a
 
-globin genes, 
 
a
 
1 and 
 
a
 
2, resides on each copy
of chromosome 16. In hemoglobin H disease, three
of these four 
 
a
 
-globin genes are affected by a dele-
tion, a mutation, or both. We studied the 
 
a
 
-globin
gene abnormalities and the clinical and hematologic
features of Chinese patients with hemoglobin H dis-
ease in Hong Kong.
 
Methods
 
We assessed the clinical features, hema-
tologic values, serum ferritin levels, and liver func-
tion of 114 patients with hemoglobin H disease. We
also performed echocardiography and magnetic res-
onance imaging of the liver and examined the two
pairs of 
 
a
 
-globin genes.
 
Results
 
Hemoglobin H disease in 87 of the 114 pa-
tients (76 percent) was due to the deletion of three
of the four 
 
a
 
-globin genes (¡¡/¡
 
a
 
), a combination
termed the deletional type of hemoglobin H. The
remaining 27 patients (24 percent) had the nondele-
tional type of hemoglobin H disease, in which two
 
a
 
-globin genes are deleted and a third is mutated
(¡¡/
 
aa
 
T
 
). All 87 patients with the deletional type of
hemoglobin H were double heterozygotes in whom
there was a deletion of both 
 
a
 
-globin genes from one
chromosome, plus a deletion of the 
 
a
 
1 or 
 
a
 
2 gene
from the other chromosome (¡¡/
 
a
 
¡ or ¡¡/¡
 
a
 
). A
variety of mutated 
 
a
 
-globin genes was found in the
patients with nondeletional type of hemoglobin H dis-
ease. Patients with the nondeletional type of the H dis-
ease had more symptoms at a younger age, more se-
vere hemolytic anemia, and larger spleens and were
more likely to require transfusions than patients with
deletional hemoglobin H disease. The severity of iron
overload was not related to the genotype.
 
Conclusions
 
Chinese patients in Hong Kong with
the nondeletional type of hemoglobin H disease have
more severe disease than those with the deletional
type of the disease. Iron overload is a major cause of
disability in both forms of the disease. (N Engl J Med
2000;343:544-50.)
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HE 
 
a
 
-thalassemias are the most common
inherited disorders of hemoglobin synthe-
sis in Southeast Asia and southern China.
Their prevalence is 3 to 5 percent in Hong
Kong
 
1,2
 
 and 30 to 40 percent in northern Thailand
and Laos.
 
3
 
 These disorders arise from deletions or
mutations (or both) of 
 
a
 
-globin genes, of which there
are four in the normal genome. The clinical mani-
festations of these genetic abnormalities range from
T
 
the silent carrier state, in which only one 
 
a
 
-globin
gene is deleted, to fatal hydrops fetalis, in which all
four 
 
a
 
-globin genes are missing. In hemoglobin H dis-
ease, a thalassemia of intermediate severity, three of
the four 
 
a
 
-globin genes are affected.
The hemoglobin molecule is a tetramer consisting
of two 
 
a
 
-globin chains and two 
 
g
 
-globin chains
(which form fetal hemoglobin in the fetus) or two
 
a
 
-globin chains and two 
 
b
 
-globin chains (which form
hemoglobin A in the adult). Balanced synthesis of
these chains (
 
a
 
 and 
 
g
 
 or 
 
a
 
 and 
 
b
 
) in erythroblasts is
important for the production of hemoglobin and
the integrity of the erythrocyte. In the 
 
a
 
-thalassemia
syndromes, there is an imbalance of globin-chain syn-
thesis as a result of a deficiency of 
 
a
 
-globin chains,
and the hematologic abnormalities of the disease re-
flect the extent of the imbalance. In addition to the
reduced hemoglobin formation caused by decreased
production of 
 
a
 
-globin chains, an excess of 
 
b
 
-globin
or 
 
g
 
-globin chains accumulates in erythroblasts and
forms tetramers. Hemoglobin H consists of tetramers
of 
 
b
 
-globin chains,
 
4
 
 and hemoglobin Bart’s is com-
posed of tetramers of 
 
g
 
-globin chains.
 
5
 
 Both tetramers
are unstable; they precipitate inside erythroblasts and
erythrocytes, causing lysis of the cells.
 
6
 
 Hemoglobin
H disease and hemoglobin Bart’s hydrops fetalis are
highly prevalent in southern China and Southeast
Asia. In Hong Kong, the incidence of hemogloblin H
disease is approximately 6 in 10,000 live births, with
48 affected babies born annually.
At the end of its short arm, chromosome 16 con-
tains a cluster of related genes, which include the two
 
a
 
-globin genes, 
 
a
 
1 and 
 
a
 
2. The 
 
a
 
-globin genotype of
a normal diploid cell is therefore 
 
a
 
2
 
a
 
1/
 
a
 
2
 
a
 
1; each
pair of the closely linked 
 
a
 
1 and 
 
a
 
2 genes is usually in-
herited as a unit, called a haplotype. There are two
types of genetic abnormalities in 
 
a
 
-thalassemia: in the
first, both 
 
a
 
-globin genes on the same chromosome
are deleted (¡¡/), and in the other, only one 
 
a
 
-glob-
in gene is affected, either by a deletion or by a non-
deletional defect (usually a point mutation). In hemo-
globin H disease, three of the four 
 
a
 
-globin genes are
affected. This results from double heterozygosity for
either the (¡¡/) haplotype plus the (/¡
 
a
 
) haplo-
type (resulting in a genotype of ¡¡/¡
 
a
 
, to indicate
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deletions of both 
 
a
 
-globin genes from one chromo-
some and the deletion of a single 
 
a
 
-globin gene from
the other), or the (¡¡/) haplotype plus the (/
 
aa
 
T
 
)
haplotype (resulting in a genotype of ¡¡/
 
aa
 
T
 
, in
which 
 
a
 
T
 
 indicates the defective 
 
a
 
-globin gene) (Fig.
1). This genetic heterogeneity contributes to the phe-
notypic diversity of hemoglobin H disease.
We assessed the clinical features and 
 
a
 
-globin gene
abnormalities in Chinese patients with hemoglobin H
disease in Hong Kong in order to provide a rational
basis for the prevention and management of the dis-
ease. Iron overload is common among older patients
(age, 35 or older) who have hemoglobin H disease,
 
7-9
 
and given the aging population in Hong Kong and
in other Chinese communities, this complication may
become a public health problem.
 
METHODS
 
Patients
 
The medical records of 114 Chinese patients with hemoglobin H
disease were reviewed between January 1998 and December 1999.
There were 93 adults and 21 children; 51 (45 percent) were male,
and 63 (55 percent) were female. The patients ranged in age from
newborn to 80 years. The majority of patients came from the Pearl
River delta area of Guangdong province in southern China. A few
were from the neighboring provinces of Guangxi and Fujian, and
one was from Henan in central China.
 
Phenotypic Analysis
 
Clinical Assessment
 
The following were determined: age at diagnosis, symptoms at
presentation, drug and transfusion histories, and whether the pa-
tient had undergone splenectomy. Each patient underwent a phys-
ical examination during a routine follow-up visit in which height,
the presence or absence of jaundice, and the size of the spleen
and liver were determined. A total of 80 patients were tested for
hepatitis B antigen, for which 9 were positive, and hepatitis C an-
tibody, for which none were positive.
 
Hematologic Measurements
 
The hemoglobin level and red-cell indexes were determined with
an electronic cell counter (model S, Coulter Electronics). Hemo-
globin electrophoresis was performed on cellulose acetate (pH 8.5);
the hemoglobin H bands and other hemoglobin bands were quan-
tified by means of elution. Hemoglobin A
 
2
 
 was assessed by micro-
column chromatography, and fetal hemoglobin was assessed by
measuring the level of alkali-resistant hemoglobin. Red cells were
stained with 1 percent brilliant cresyl blue (2:1) in citrate–saline
at 37°C for 30 minutes and then examined microscopically for
hemoglobin H inclusions.
 
Iron Studies
 
Serum ferritin was measured with a chemiluminescence immu-
noassay (Corning Magic Lite and Chiron Diagnostics). Serum iron
was analyzed by a colorimetric method (model 717, Hitachi and
Boehringer Mannheim). Liver function, including measurement of
aspartate aminotransferase, alanine aminotransferase, bilirubin, al-
kaline phosphatase, and lactate dehydrogenase, was assessed with
use of a multichannel analyzer (model 747, Hitachi and Boehringer
Mannheim).
 
Magnetic Resonance Imaging
 
Magnetic resonance imaging (MRI) studies were performed in
60 successive patients over the age of 18 years; a 1.5-T system
(Signa, General Electric Medical Systems) was used. The paramag-
netic effects of iron reduce the signal intensity (resulting in hy-
pointensity) in the affected organs. Iron overload is evaluated on the
basis of the ratio of the signal intensity of a particular organ to the
signal intensity of either fat or paraspinous muscle. A signal-inten-
sity ratio of less than 1 indicates iron overload, and the T
 
2
 
-weight-
ed gradient-echo sequence has been shown to be the most effi-
cient approach to determining the signal-intensity ratio.
 
10-13
 
 We
applied this validated method of iron quantification using para-
spinous muscle as an internal standard for both qualitative assess-
ment of iron overload (in which a grade of 1 was considered to
indicate normal iron levels, a grade of 2 mild iron overload, a grade
of 3 moderate iron overload, and a grade of 4 severe iron over-
load) and quantitative assessment of iron overload (defined as a
signal-intensity ratio of less than 1) on T
 
2
 
-weighted images.
 
10
 
Echocardiography
 
We performed echocardiography in 25 randomly selected pa-
tients who were older than 18 years of age (8 men and 17 women;
mean [±SD] age, 48±16 years) who had no history or signs of
heart failure, using a computed sonograph (model 128 XP/10C,
Accuson). Left ventricular ejection fraction and blood flow across
the mitral valve were measured with the use of pulsed Doppler
ultrasonography. The peak early diastolic flow and the peak late
diastolic flow were measured; a ratio of the peak velocity of blood
flow across the mitral valve in early diastole to that in late diastole
as a result of atrial contraction of less than 1 is suggestive of an im-
pairment in left ventricular relaxation. Isovolumic relaxation time
is the interval between the closure of the aortic valve and the open-
ing of the mitral valve. An isovolumic relaxation time of more than
100 msec is suggestive of abnormal left ventricular relaxation.
 
Liver Biopsy
 
Liver biopsy was performed in six patients with elevated ferritin
levels, abnormal liver function, or both. Liver iron content was
quantitated by histologic grading of hemosiderotic granules.
 
10
 
Figure 1.
 
 The Mode of Inheritance of Forms of Hemoglobin H
Disease Involving Deletions and Other Types of Mutations.
The genotype of the parents is shown at the top. Normal 
 
a
 
-globin
genes are represented by open boxes, and mutated, nondelet-
ed 
 
a
 
-globin genes (
 
a
 
T
 
) by hatched boxes. The genotypes of the
offspring are shown in parentheses.
DeletionalF
(¡¡/a¡)
X
NondeletionalF
(¡¡/aaT)
Parent 1F
ChildF ChildF
Parent 2F Parent 1F Parent 2F
X
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Genotypic Analysis
Restriction-Endonuclease Mapping
DNA from peripheral-blood leukocytes was digested with re-
striction enzymes BamHI, EcoRI, and BglII according to the man-
ufacturer’s instructions (New England Biolabs). Samples then un-
derwent electrophoresis, Southern blotting, and hybridization to
a z-globin probe labeled with phosphorus-32 for the identification
of gene deletions.1
Allele-Specific Oligonucleotide Hybridization 
and Direct Genomic Sequencing
For the detection of nondeletional defects, the a2 and a1 genes
of the patients were specifically amplified by the polymerase chain
reaction (PCR)14 and hybridized to oligonucleotides specific for the
four common nondeletional a-globin gene defects: the Constant
Spring variant (aCS), in which CAA is substituted for TAA at
codon 142 of a2 (TAA→CAA); the Quong Sze variant (aQS) in
which CCG is substituted for CTC at codon 125 of a2; the de-
letion of GAG (∆GAG) at codon 30 of a2; and the substitution
of GAC for GGC at codon 59 of a2.15
Unknown nondeletional defects were characterized by direct
genomic sequencing of the PCR-amplified a2 and a1 genes.14
Screening for Hereditary Hemochromatosis
The 60 patients who underwent MRI were also screened for
three known mutations of the hemochromatosis gene: the substi-
tution of tyrosine for cysteine at position 282 (C282Y), the sub-
stitution of aspartic acid for histidine at position 63 (H63D), and
the substitution of cysteine for serine at position 65 (S65C). The
C282Y mutation creates a new SnaBI site, whereas the H63D and
S65C mutations remove an MboI and Hinf I site, respectively, in
PCR-amplified DNA.16,17
Statistical Analysis
Statistical analyses were conducted with an SSPS software pro-
gram. Student’s t-test was used to compare continuous data, and
the chi-square test was used for categorical variables. Spearman’s
correlation coefficient was used to express the correlation between
variables.
RESULTS
Genotypes
Table 1 lists the frequencies of various hemoglo-
bin H genotypes among the 114 patients. There were
87 (/¡a) and 27 (/aaT) haplotypes. In all but one of
the patients, a 20-kb deletion that is typical of a-thal-
assemia in patients in Southeast Asia accounted for
the (¡¡/) haplotypes; in the remaining patient, the
entire cluster of genes related to the a-globin locus
was deleted.18 Among the deletional (/¡a) haplo-
types, a 3.7-kb deletion of the a-globin genes (/a¡3.7)
affecting the rightward a1 gene accounted for about
two thirds of cases, and a 4.2-kb deletion (/a¡4.2) af-
fecting the leftward a2 gene made up the rest, in-
cluding two that were associated with a structural mu-
tation of the a-globin gene (hemoglobin Q). Among
the nondeletional (/aaT) haplotypes, the Constant
Spring variant was the most common, followed by
the Quong Sze variant. Both are due to point mu-
tations in the a-globin gene, at codons 142 and 125,
respectively. Four patients had a deletion at codon 30
of a2, and one had a mutation at codon 59 of a2.
A novel mutation at codon 31 of a2 (AGG→AAG)
was identified in two sisters. 
Clinical Features
Hemoglobin H disease is usually of intermediate
severity. Only 24 percent of the patients presented
with symptoms directly related to the disease, such as
jaundice (2 percent), symptoms of anemia (11 per-
cent), and gallstones (11 percent). In most patients
(76 percent), the diagnosis was made incidentally after
they presented with infections, during a work-relat-
ed health assessment, or on hematologic examina-
tion during pregnancy.
Of 77 adults who underwent ultrasonography, 26
had gallstones; 5 of these 26 underwent cholecystec-
tomy. Among children, the rate of growth was below
the third percentile for age in 13 percent. Neither
gallstones nor growth retardation was related to the
genotype. A few patients had very mild dysmorphic
facial features. Of the 114 patients, 53 (46 percent)
had been treated with transfusions. Except for the one
patient who presented with hydrops fetalis as a result
of the GGC→GAC mutation at codon 59 of the a2
gene,14 and who had been dependent on transfusions
since undergoing transfusion in utero, the patients
were not transfusion-dependent. The median number
of transfusions was 1.4, and only eight patients had
received 5 or more transfusions (median number,
5.5; range, 5 to 20). Two siblings with the Constant
Spring variant and massive splenomegaly required reg-
ular transfusions until they underwent splenectomy.
Other patients received transfusions because of ane-
mia during pregnancy or infection.
Table 2 shows the clinical and laboratory findings
in the patients. Patients with a nondeletional haplo-
type had more severe clinical features than patients
with a deletional haplotype; a larger proportion of
them were symptomatic at presentation (40 percent
*Two sisters had this mutation.
TABLE 1. FREQUENCY OF VARIOUS HEMOGLOBIN H GENOTYPES 
AMONG THE 114 PATIENTS.
TYPE OF MUTATION GENOTYPE
NO. OF 
PATIENTS (%)
Deletion
Rightward deletion of 3.7 kb of the 
a-globin gene
Leftward deletion of 4.2 kb of a2 
Leftward deletion in gene for a-globin 
chain associated with hemoglobin Q
¡¡/¡a¡3.7 
¡¡/¡a¡4.2 
¡¡/¡aQ
64 (56)
21 (18)
2 (2)
Nondeletion
TAA→CAA at codon 142 (hemo-
globin Constant Spring variant)
CTG→CCG at codon 125 (hemo-
globin Quong Sze variant)
∆GAG at codon 30 of a2
AGG→AAG at codon 31 of a2
GGC→GAC at codon 59 of a2
¡¡/aCSa
¡¡aQSa
¡¡/a∆30a
¡¡/a31a
¡¡/a59a
15 (13)
5 (4)
4 (4)
2 (2)*
1 (1)
Total 114 (100)
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vs. 23 percent), were younger at diagnosis (mean,
10.8 vs. 22.6 years), had larger spleens (4.62 vs. 1.52
cm) and were more likely to have received a transfu-
sion (81 percent vs. 42 percent). They also had more
severe anemia (hemoglobin level, 8.4 vs. 9.5 g per
deciliter), had higher proportions of hemoglobin H
(15.9 percent vs. 7.3 percent) and hemoglobin Bart’s
(2.7 percent vs. 0.68 percent), and more severe he-
molysis, as indicated by higher mean corpuscular vol-
umes (73.8 vs. 63.6 µm3), reticulocyte counts (5.9
vs. 4.2 percent), and lactate dehydrogenase levels (900
vs. 442 U per liter).
All patients were screened for the glucose-6-phos-
phate dehydrogenase deficiency, and only three were
positive for the deficiency. None of the three had
more severe anemia than did patients without the
deficiency.
Iron Overload
Figure 2A shows the relation between serum fer-
ritin levels and age. The ferritin level increased sig-
nificantly with age (P<0.001) and was not related to
transfusion history. There was no significant differ-
ence in results between male and female patients or
between patients with deletional haplotypes and those
with nondeletional haplotypes. MRI of the liver
showed a signal-intensity ratio of less than 1 in 85
percent of the patients who underwent MRI (51 of
60), and there was an inverse relation between the
ratio and serum ferritin levels (P<0.001) (Fig. 2B),
indicating that liver iron content increased with high-
er ferritin levels. Liver biopsy performed in six pa-
tients who had elevated serum ferritin levels, abnor-
mal liver function, or both (Table 3) showed fibrosis
in five and cirrhosis in two. All six had a moderate or
severe iron overload on qualitative MRI and quanti-
tative MRI (mean signal-intensity ratio, 0.14±0.18)
and an abnormal liver iron content. All six patients
had negative serologic tests for hepatitis B and C and
other known causes of liver disease. None were re-
ceiving long-term iron therapy or herbal remedies. 
Echocardiography in 25 patients who had no his-
tory or symptoms of heart failure showed a normal
ejection fraction (mean, 62±7 percent; range, 50 to
*Plus–minus values are means ±SD.
TABLE 2. CHARACTERISTICS OF 114 PATIENTS WITH HEMOGLOBIN 
H DISEASE, ACCORDING TO THE TYPE OF MUTATION.*
CHARACTERISTIC 
DELETION
(N=87)
NONDELETION
(N=27) P VALUE
Age at diagnosis (yr)
Mean
Median 
22.6±16.9
20
10.8±11.0
5
<0.001
Symptoms at presentation (%) 23 40 0.07
History of transfusion (%) 42 81 <0.001
Abnormal liver function (%) 17 50 0.001
Aspartate aminotransferase 
(U/liter)
25.1±11.0 38.4±21 0.001
Spleen size (cm) 1.52±1.99 4.62±4.1 <0.001
Splenectomy (%) 5 31 <0.001
Liver size (cm) 0.8±1.4 1.2±1.6 0.2
Lactate dehydrogenase (U/liter) 442±193 900±864 0.004
Ferritin (ng/ml) 536±649 841±1000 0.1
Signal-intensity ratio of liver 0.52±0.52 0.1±0.089 0.002
Hemoglobin (g/dl) 9.5±1.3 8.4±1.6 0.003
Red cells (¬10¡6/mm3) 5.0±0.7 4.1±0.7 <0.001
Mean corpuscular volume (µm3) 63.6±5.6 73.8±6.7 <0.001
Mean corpuscular hemoglobin (pg) 18.7±1.7 20.2±1.8 0.001
Mean corpuscular hemoglobin 
concentration (g/dl)
29.3±1.7 27.3±2.4 0.001
Reticulocytes (%) 4.2±2.5 5.9±3.4 0.03
Hemoglobin H (%) 7.3±3.6 15.9±8.0 <0.001
Hemoglobin A2 (%) 1.2±0.1 0.9±0.6 0.002
Fetal hemoglobin (%) 1.3±0.64 2.3±2.0 <0.001
Hemoglobin Bart’s (%) 0.68±0.9 2.7±2.5 <0.001
Figure 2. Correlation between Serum Ferritin Levels and the
Age of the Patients (Panel A) and the Ratio of the Signal Inten-
sity in the Liver to the Signal Intensity in Paraspinous Muscle
on a T2-Weighted Gradient-Echo Magnetic Resonance Imaging
Sequence (Panel B).
A signal-intensity ratio of less than 1 indicates iron overload.
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74 percent). However, the diastolic function was not
in the normal range derived from assessments of 25
normal age-matched controls. The ratio of the peak
velocity of blood flow across the mitral valve in early
diastole to that in late diastole as a result of atrial
contraction was 2.01±0.88 in the patients, as com-
pared with 1.34±0.40 in the controls (P<0.001).
The isovolumic relaxation time was 64.8±11.5 msec
in the patients, as compared with 88.7±13.5 msec
in the controls (P<0.001). Moreover, an increase in
serum ferritin levels was significantly related to a de-
crease in the ratio of the peak velocity of blood flow
across the mitral valve in early diastole to that in late
diastole as a result of atrial contraction (P=0.007)
and to an increase in the isovolumic relaxation time
(P=0.04) (Fig. 3).
None of the patients studied by MRI or echocar-
diography carried the C282Y or the S65C mutation
in the hemochromatosis gene. One patient was het-
erozygous for the H63D mutation, and his serum
ferritin level was 1750 ng per milliliter.
DISCUSSION
The clinical variability of hemoglobin H disease in
Hong Kong can be explained in part by the diversity
of genetic abnormalities that can cause the disease.
Of the 114 patients we studied, 76 percent had the
deletional genotype, and 24 percent had the nonde-
letional genotype. As in many other genetic diseases,
the incidence of genetic subtypes of hemoglobin H
disease varies in different ethnic groups. By contrast
with our patients from southern China, those in Thai-
land and Guangxi province (southwest of Guangdong,
near Thailand) have a higher incidence of nondele-
tional hemoglobin H disease (40 to 60 percent).3,19
We confirmed20-24 that patients with nondeletion-
al hemoglobin H disease have more severe anemia,
hemolysis, and splenomegaly and are more likely to
require transfusions than those with the deletional
type of the disease. This clinical difference reflects a
greater decrease in the synthesis of a-globin chains
in patients with nondeletional defects; in our study,
most such mutations occurred in the a2 gene. The a2
gene normally controls the synthesis of three quar-
ters of the a-globin chains, whereas the downstream
a1 gene controls one quarter.25,26 Mutant forms of
the a2 gene probably retain normal transcriptional
activity, but there is no protein product. Transcrip-
tion of the mutant a2 gene interferes with transcrip-
tion of the normal a1 gene, resulting in reduced
synthesis of normal a-globin chains.27 We found that
the two types of deletional hemoglobin H disease,
in which only one functional gene remained (either
a1 or a2), are clinically similar, because in either sit-
uation, transcription of a single a-globin gene can
occur without interference.
Of the patients with nondeletional hemoglobin H
disease, those with the Constant Spring variant have
an additional mechanism for hemolysis because the
variant chains damage the red-cell membrane directly,
causing an increased influx of water that is followed
by hemolysis.28,29 These chains also form tetramers
with b-globin chains (creating hemoglobin Constant
Spring), thereby reducing the number of free b-globin
chains available to form b-globin tetramers (i.e., he-
moglobin H). Nevertheless, the mean hemoglobin
H level in patients with the Constant Spring variant
(12.3±4.8 percent) was higher than in patients with
deletional hemoglobin H disease. Patients with the
Quong Sze variant and those with the ∆GAG muta-
tion at codon 30 of a2 had even higher hemoglobin
H levels (21.1±2.2 percent and 21.9±7.5 percent,
respectively), because their mutant a-globin chains are
unstable, degrade rapidly, and do not form an abnor-
mal hemoglobin with the excess b-globin chains.21,30
Since most patients with hemoglobin H disease
lead normal lives and have treatable late complications,
prenatal testing for the disease is usually unwarrant-
ed. However, hydrops fetalis has been reported in two
fetuses, one with the GGC→GAC mutation at codon
59 of a2 and one with compound heterozygosity for
the deletion of the z–a-globin gene cluster and the
∆GAG mutation at codon 30 of a2.14,18,21 Prenatal
diagnosis and termination of such affected pregnan-
cies are advisable.
The major complications in patients with hemoglo-
bin H disease result from iron overload. The increase
in serum ferritin levels is correlated with age but is
unrelated to the genotype. In 85 percent of the pa-
tients who underwent MRI of the liver, liver iron con-
*The degree of iron overload was assessed according to the method of
Ooi et al.10
†The amount of iron in the liver was assessed with use of a four-point
scale in which a grade of I indicates normal levels and grades of II, III, and
IV increasing amounts of iron.12
‡Patient 1 had had recent gastrointestinal bleeding.
TABLE 3. LIVER-BIOPSY FINDINGS IN SIX PATIENTS 
WITH INCREASED FERRITIN LEVELS, 
ABNORMAL LIVER FUNCTION, OR BOTH.
PATIENT
NO.
SEX/
AGE
(YR)
FERRITIN
(ng/ml)
GRADE 
OF IRON
OVERLOAD
ON MRI* LIVER-BIOPSY FINDINGS
FIBROSIS CIRRHOSIS IRON†
1 F/31 304‡ Moderate Minimal Absent II
2 F/44 1168 Severe Mild Absent II
3 F/57 1232 Severe Absent Absent II
4 F/60 2240 Severe Minimal Absent III
5 F/59 2880 Severe Severe Early IV
6 F/55 3560 Severe Very severe Established IV
Normal
values
6–353 Normal Absent Absent I
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tent was also increased. The inverse relation between
the signal-intensity ratio on MRI of the liver and se-
rum ferritin levels indicates that hepatic iron content
increases with age. MRI has also been used to detect
iron overload in patients with hemochromatosis11,13
and transfusion-dependent thalassemia.31 The limi-
tations of MRI are that it underestimates iron levels
in organs if the levels are extremely high and that the
signal intensity varies in patients with advanced cir-
rhosis.32,33 Neither of these problems was encoun-
tered in our patients.
In three of our patients with hemoglobin H dis-
ease, heart failure developed as a result of severe iron
overload, although they had not received long-term
transfusion therapy and they did not have any of the
known mutations of the hemochromatosis gene or
other contributing factors. Among the adult patients
with asymptomatic hemoglobin H disease who un-
derwent echocardiography in our study, diastolic func-
tion was abnormal and there was a trend toward in-
creasing abnormality with increasing serum ferritin
levels. Such abnormal diastolic function has been
shown to precede left ventricular systolic dysfunction
in patients with thalassemia major34,35; we can use
these measurements to monitor patients with asymp-
tomatic hemoglobin H disease before heart failure
due to iron overload develops.
Iron overload in patients with hemoglobin H dis-
ease who do not require transfusions has been re-
ported in other Asian patients,7-9 but not in patients
of Mediterranean origin.36,37 The latter were children,
and we have shown in the current study that iron
overload is time-dependent. The coinheritance of he-
reditary hemochromatosis as a possible cause of iron
overload was ruled out in all but one of our patients,
who was found to be a carrier of the H63D mutation
in the hemochromatosis gene, but his serum ferritin
level was not significantly higher than that of the oth-
er patients. This incidence of the H63D mutation
(1 in 60, or 1.7 percent) in our group is similar to
Figure 3. Relation between the Serum Ferritin Level and the Ratio of the Peak Velocity of
Blood Flow across the Mitral Valve in Early Diastole to That in Late Diastole Due to Atrial
Contraction (Panel A) and the Isovolumic Relaxation Time (Panel B).
A ratio of less than 1 is suggestive of an impairment in left ventricular relaxation. An iso-
volumic relaxation time of more than 100 msec is suggestive of abnormal left ventricular
relaxation.
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the 2.7 percent incidence reported among Chinese in
Australia and is much lower than that among whites.38
For these reasons, iron overload in our group can
best be explained by the increased absorption of di-
etary iron resulting from hemolysis and ineffective
erythropoiesis.39
In patients with transfusion-dependent b-thalas-
semia major, iron deposits are mostly in the Goe-
thite form, as opposed to the smaller ferrihydride
form that occurs in patients with non–transfusion-
dependent thalassemia intermedia.40,41 The ferrihy-
dride form causes more tissue damage, because it is
less crystalline and releases more toxic oxygen free
radicals. Therapeutic intervention may therefore be
indicated at much lower ferritin levels in patients with
non–transfusion-dependent thalassemia, such as he-
moglobin H disease, than in patients with thalassemia
major, for whom the threshold for starting chelation
therapy is a serum ferritin level of 1000 ng per millili-
ter. Therefore, we propose that patients with hemoglo-
bin H disease should be closely monitored for tissue
damage due to iron overload, and chelation therapy
should be initiated once such damage is detected.
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